Abstract
Background
Juvenile idiopathic arthritis (JIA) is the most common of all systemic conditions associated with childhood uveitis. Visual impairment has been shown to be as high as 40% of which 10% being blind (6/60 or worse). Due to the lack of well-designed randomized control trials for paediatric uveitis and arthritis there are limited comparative data regarding the efficacy of single or combination treatments. Recently, abatacept was shown to control ocular inflammation in a case of psoriatic arthritis- associated uveitis, seven cases of JIA- associated uveitis and in JIA. We present two cases with JIA-associated uveitis who have responded dramatically to abatacept therapy following unsuccessful therapy with other immunosuppressants. Control of arthritis still represents a challenge with this treatment.
Methods
Prospective review of two patients with refractory JIA- associated uveitis not responding to maximum conventional treatment. Patients were regularly reviewed in the ophthalmology and rheumatology clinics. Assessment of their ocular condition was characterized according to the Standardization of Uveitis Nomenclature (SUN) group.
Results
In case 1, ocular inflammation was brought under control after repeated abatacept infusions. Case 2 showed complete resolution of cystoids macular edema CME and improvement of 5 Snellen’s lines in best corrected visual acuity. After 9 months, the ocular condition of both patients remains in remission with steroid sparing. Joint disease was brought to clinical remission in case 2, but not in case 1.
Conclusions
Abatacept is a promising alternative treatment in refractory cases of JIA uveitis but may not be as successful in controlling joint disease. Larger series with long term follow up of biological therapies in paediatric uveitis are essential to assess the efficacy and cost effectiveness.
Reference
BenEzra D, Cohen E, Maftzir G (2005) Uveitis in children and adolescents. Br J Ophthalmol 89:444–448
Ozdal PC, Vianna RNG, Deschenes J (2005) Visual outcomes of juvenile rheumatoid arthritis associated uveitis in adults. Ocular Immunol Inflamm 13:133–138
Smith JR (2002) Management of uveitis in pediatric patients: special considerations. Paediatr Drugs 4:183–189
Olson NY, Lindsley CB, Godfrey WA (1988) Nonsteroidal anti-inflammatory drug therapy in chronic childhood iridocyclitis. Am J Dis Child 142:1289–1292
Kotaniemi K, Savolainen A, Karma A, Aho K (2003) Recent advances in uveitis of juvenile idiopathic arthritis. Surv Ophthalmol 48:489–502
Sharma SM, Nestel AR, Lee RW, Dick AD (2009) Clinical review: anti-TNFα therapies in uveitis: perspective on 5 years of clinical experience. Ocul Immunol Inflamm 17:403–414
Biester S, Deuter C, Michels H, Haefner R, Kuemmerle-Deschner J, Doycheva D, Zierhut M (2007) Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol 91:319–324
Angeles-Han S, Flynn T, Lehman T (2008) Abatacept for refractory juvenile idiopathic arthritis-associated uveitis – a case report. J Rheumatol 35:1897–18989
Zulian F, Balzarin M, Falcini F, Martini G, Alessio M, Cimaz R, Cimino L, Zannin ME (2010) Abatacept for severe anti-TNFalpha refractory juvenile idiopathic arthritis-related uveitis. Arthritis Care Res (Hoboken) 62(6):821–825
Ruperto N, Lovell DJ, Quartier P, Paz E, Rubio-Pérez N, Silva CA, Abud-Mendoza C, Burgos-Vargas R, Gerloni V, Melo-Gomes JA, Saad-Magalhães C, Sztajnbok F, Goldenstein-Schainberg C, Scheinberg M, Penades IC, Fischbach M, Orozco J, Hashkes PJ, Hom C, Jung L, Lepore L, Oliveira S, Wallace CA, Sigal LH, Block AJ, Covucci A, Martini A, Giannini EH, Paediatric Rheumatology International Trials Organization, Pediatric Rheumatology Collaborative Study Group (2008) Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial. Lancet 372:383–391
Yvonne S (2008) Abatacept in biologic-naive patients and TNF inadequate responders: clinical data in focus. Curr Med Res Opin 24:2283–2294
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors have no competing interests
Rights and permissions
About this article
Cite this article
Kenawy, N., Cleary, G., Mewar, D. et al. Abatacept: a potential therapy in refractory cases of juvenile idiopathic arthritis-associated uveitis. Graefes Arch Clin Exp Ophthalmol 249, 297–300 (2011). https://doi.org/10.1007/s00417-010-1523-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-010-1523-6